NCT07369752 Enhancing Brain And Mental Health Through Breathing Practice
| NCT ID | NCT07369752 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Depressive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-02-19 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-02-19 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the feasibility of a structured breathing intervention in rural and non-rural adolescents diagnosed with anxiety and depression, recruited from outpatient pediatric and child/adolescent psychiatry clinics.
Eligibility Criteria
Inclusion Criteria: * Adolescents between the ages of 12 and 17 who have been diagnosed with a major depressive disorder (mild or moderate) and/or an anxiety disorder. * Participants may have co-occurring mild to moderate alcohol or drug use problems, provided these do not require immediate specialized treatment or crisis intervention. * All participants must be receiving care at one of two participating MCHS outpatient psychiatry clinics and may reside in rural area (RUCA code 4-10) or non-rural area. * Participants must be able to read and understand English, and both parental or guardian consent and adolescent assent will be required. Exclusion Criteria: * Current suicidal ideation or self-harm behavior requiring immediate clinical intervention * Presence of severe psychiatric comorbidities such as psychosis, bipolar disorder, depression with psychotic features, severe alcohol and drug use, or eating disorders. * Participants with significant cognitive impairment that would interfer
Frequently Asked Questions
Who can join the NCT07369752 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07369752 currently recruiting?
Yes, NCT07369752 is actively recruiting participants. Visit ClinicalTrials.gov or contact Mayo Clinic to inquire about joining.
Where is the NCT07369752 trial being conducted?
This trial is being conducted at Albert Lea, United States, Eau Claire, United States.
Who is sponsoring the NCT07369752 clinical trial?
NCT07369752 is sponsored by Mayo Clinic. The trial plans to enroll 40 participants.